NeuroSense Therapeutics Ltd. NRSNW
Set alert
0.01 USD 0.00 +24.00%
As of Oct 30, 10:13 AM ET
0.0075 Day range 0.0075
0.0075 52-week range 0.0093
- YTD
- +24.00%
- 1 year
- +24.00%
- Open
- 0.30
- Prev close
- 0.0075
- Mkt cap
- 185.00K
- Vol
- 7
- Avg vol
- 0
- EPS
- -0.935
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.0075
- High
- 0.0075
- Forward P/E
- 0.00
- Beta
- 1.56
- Short ratio
- 0.00
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.00
- 200-d avg
- 0.00
- 1y target
- 0.00
Financial health
FMP rating
D+1 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -1.7×
FY 2019 5y median -1.7× FY 2025
P/S 0.0×
FY 2019 5y median 0.0× FY 2025
P/B -12.6×
FY 2019 5y median 2.5× FY 2025
P/FCF -2.6×
FY 2019 5y median -2.2× FY 2025
EV/EBITDA -1.8×
FY 2019 5y median -1.8× FY 2025
EV/Sales 0.0×
FY 2019 5y median 0.0× FY 2025
FCF Yield -39.2%
FY 2019 5y median -45.4% FY 2025
Profitability
Gross Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2019 5y median 0.0% FY 2025
ROE 713.1%
FY 2019 5y median -44.9% FY 2025
ROIC 797.5%
FY 2019 5y median -51.6% FY 2025
ROA -1082.2%
FY 2019 5y median -223.2% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2019 FY 2025
Operating Income -11.9%
FY 2019 FY 2025
EPS (diluted) 20.0%
FY 2019 FY 2025
Free Cash Flow 24.3%
FY 2019 FY 2025
Financial Health
Current Ratio 0.3×
FY 2019 5y median 2.2× FY 2025
Quick Ratio 0.3×
FY 2019 5y median 2.2× FY 2025
Debt / Equity -0.1×
FY 2019 5y median 0.0× FY 2025
Net Debt / EBITDA -0.0×
FY 2019 5y median 0.3× FY 2025
Interest Coverage 0.0×
FY 2019 5y median -21.9× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31